Among the eight potential key metabolites, sphinganine 1-phosphate is able to protect against the development of hepatic insulin resistance by activating the Akt pathway via the receptor subtypes S1PR1 and/or S1PR3 and by enhancing mitochondrial functions [51]. Here, AKT1 is linked to Insulin resistance.